Photo: Garry Mcleod; Origami: Robert Lang – from Wired Magazine, “Inside the Battle to Define Mental Illness”
In 1952, the first hydrogen bomb was detonated and the American Psychiatric Association, APA, published its first book of mental illnesses: the Diagnostic and Statistical Manual of Mental Disorders, DSM.
No one, then, could have imagined that this seemingly innocuous manual would be more destructive, and result in producing more victims, than a nuclear weapon.
Since then the DSM has mushroomed and with each revised DSM untold millions carry the scars from its devastating effects.
Oddly enough, governments seem oblivious to the fallout of psychiatry’s arbitrary and devastating mental illness labels. Why? Could the answer lie in the extraordinarily profitable relationship between psychiatry and the pharmaceutical industrial complex?
The fact is pharmaceutical companies can’t push their latest mind-altering chemical concoctions until the deep-thinkers of psychiatry first vote the mental illness into existence. Then, unfortunately, the unsuspecting public becomes ground zero for these pharmaceutical Weapons of Mental Destruction (WMD).
How lucky, then, for the pharmaceutical industry. Very soon the APA will introduce its updated book of mental illnesses, the DSM-V. The APA’s latest book of behaviors it believes are abnormal actually may read longer than Leo Tolstoy’s War and Peace.
More importantly, though, according to recent reports, the newest book of mental disorders is not only horribly flawed but also is more dangerous than its previous version – the whopping 886-page DSM-IV-TR.
In fact, Allen J. Frances, M.D., former chairman of the APA’s DSM-IV Task Force and long-time cheerleader of the APA’s apparent philosophy of “we-can-find-a-mental illness-for-every-human-emotion,” now oddly has become an outspoken critic of the upcoming release of the DSM-V.